asa guidelines on glp-1 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations the peri-procedural use of GLP-1/GIP receptor agonists Anesthetic Considerations for Patients Taking
Description
Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption
Design emails and forms that look great on any device
Furthermore, these agents modulate inflammation, reduce apoptosis, and improve stem cell functions even under diabetic or inflammatory conditions
Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation
